Valeur (ajoutée) du pharmacien clinicien dans le service d'oncologie et optimalisation de l'applicabilité d'outils gériatriques évaluant l'utilisation potentiellement inadéquate de médicaments chez les patients gériatriques (Drug Burden Index et critères de Beers).

Translated title: [(Added) Value of a clinical pharmacist in the oncology department and optimalisation of the applicability of geriatric tools assessing potential inappropriate medication use in geriatric patients (Drug Burden Index and de Beers criteria)].

J. Van Den Broucke*, A. Verhaeghe, P. R. Debruyne, K. Verhelle

*Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review

Abstract

In a pilot project, the value of a clinical pharmacist in the oncology department is examined. There is special attention given to two clinical pharmaceutical criteria concerning use of potential inappropriate drugs in this population. First of all, the Drug Burden Index (DBI), a measurement of the individual exposure to anticholinergic and sedative drugs. Second of all, the Beers criteria, an explicit criterion of potential inappropriate use of drugs by the geriatric patient. Criteria are adapted for application in Belgian practice. It can be concluded that the clinical pharmacist can be used to support the multidisciplinary approach to cancer patients. The use of the two criteria mentioned above in the estimation of the clinical impact of drugs on functional outcome and cognition on the (oncolgeriatric patient and the correlation with hard endpoints, still need to be investigated.

Translated title[(Added) Value of a clinical pharmacist in the oncology department and optimalisation of the applicability of geriatric tools assessing potential inappropriate medication use in geriatric patients (Drug Burden Index and de Beers criteria)].
Original languageFrench
Pages (from-to)28-36
Number of pages9
JournalJournal de pharmacie de Belgique
Issue number1
Publication statusPublished - Mar 2014
Externally publishedYes

ASJC Scopus subject areas

  • General Medicine

Fingerprint

Dive into the research topics of '[(Added) Value of a clinical pharmacist in the oncology department and optimalisation of the applicability of geriatric tools assessing potential inappropriate medication use in geriatric patients (Drug Burden Index and de Beers criteria)].'. Together they form a unique fingerprint.

Cite this